dexa scans hologic discovery model a Search Results


dxa scans  (Hologic Inc)
86
Hologic Inc dxa scans
Multivariable-adjusted associations between ( A ) baseline and ( B ) time-varying adiposity variables and breast cancer-related mortality in the Women’s Health Initiative dual-energy X-ray absorptiometry cohort ( n = 9767; breast cancer-related deaths: 87). VAT, SAT, and TAT per 100 cm 2 are limited to the new 5 cm high abdominal region of interest. Multivariable models adjusted for: age at baseline, region, education, income, race and ethnicity, hormone therapy trial arm, diet modification trial arm, calcium and vitamin D trial arm, height at baseline, alcohol intake, smoking status, physical activity (MET-hrs/wk), physical function (SF 36 score), total energy intake (kcal/day), HEI-2015 score, hormone therapy, aspirin, metformin, female relative with breast cancer, age at menarche, age at first birth, total number of months of breastfeeding, age at menopause, and surgical menopause. VAT: Visceral adipose tissue; SAT: Abdominal subcutaneous adipose tissue; TAT: Total abdominal adipose tissue; Q: Quartile; SHR: Sub-hazard ratio; CI: Confidence interval; WHI: Women’s Health Initiative; <t>DXA:</t> Dual-energy X-ray absorptiometry.
Dxa Scans, supplied by Hologic Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dexa+scans+hologic+discovery+model+a/body+dxa+scans+whole/pmc12939695-189-2-14
Average 86 stars, based on 1 article reviews
dxa scans - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier
x ray absorptiometry model  (Hologic Inc)
86
Hologic Inc x ray absorptiometry model
Multivariable-adjusted associations between ( A ) baseline and ( B ) time-varying adiposity variables and breast cancer-related mortality in the Women’s Health Initiative dual-energy X-ray absorptiometry cohort ( n = 9767; breast cancer-related deaths: 87). VAT, SAT, and TAT per 100 cm 2 are limited to the new 5 cm high abdominal region of interest. Multivariable models adjusted for: age at baseline, region, education, income, race and ethnicity, hormone therapy trial arm, diet modification trial arm, calcium and vitamin D trial arm, height at baseline, alcohol intake, smoking status, physical activity (MET-hrs/wk), physical function (SF 36 score), total energy intake (kcal/day), HEI-2015 score, hormone therapy, aspirin, metformin, female relative with breast cancer, age at menarche, age at first birth, total number of months of breastfeeding, age at menopause, and surgical menopause. VAT: Visceral adipose tissue; SAT: Abdominal subcutaneous adipose tissue; TAT: Total abdominal adipose tissue; Q: Quartile; SHR: Sub-hazard ratio; CI: Confidence interval; WHI: Women’s Health Initiative; <t>DXA:</t> Dual-energy X-ray absorptiometry.
X Ray Absorptiometry Model, supplied by Hologic Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dexa+scans+hologic+discovery+model+a/absorptiometry+dual+energy+ray+x/10__4103_slash_joah__joah_22_24-64-6-21
Average 86 stars, based on 1 article reviews
x ray absorptiometry model - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier
dexa system  (Hologic Inc)
86
Hologic Inc dexa system
Multivariable-adjusted associations between ( A ) baseline and ( B ) time-varying adiposity variables and breast cancer-related mortality in the Women’s Health Initiative dual-energy X-ray absorptiometry cohort ( n = 9767; breast cancer-related deaths: 87). VAT, SAT, and TAT per 100 cm 2 are limited to the new 5 cm high abdominal region of interest. Multivariable models adjusted for: age at baseline, region, education, income, race and ethnicity, hormone therapy trial arm, diet modification trial arm, calcium and vitamin D trial arm, height at baseline, alcohol intake, smoking status, physical activity (MET-hrs/wk), physical function (SF 36 score), total energy intake (kcal/day), HEI-2015 score, hormone therapy, aspirin, metformin, female relative with breast cancer, age at menarche, age at first birth, total number of months of breastfeeding, age at menopause, and surgical menopause. VAT: Visceral adipose tissue; SAT: Abdominal subcutaneous adipose tissue; TAT: Total abdominal adipose tissue; Q: Quartile; SHR: Sub-hazard ratio; CI: Confidence interval; WHI: Women’s Health Initiative; <t>DXA:</t> Dual-energy X-ray absorptiometry.
Dexa System, supplied by Hologic Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dexa+scans+hologic+discovery+model+a/dexa/pm41253299-60-19-26
Average 86 stars, based on 1 article reviews
dexa system - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier
densitometer  (Hologic Inc)
86
Hologic Inc densitometer
Multivariable-adjusted associations between ( A ) baseline and ( B ) time-varying adiposity variables and breast cancer-related mortality in the Women’s Health Initiative dual-energy X-ray absorptiometry cohort ( n = 9767; breast cancer-related deaths: 87). VAT, SAT, and TAT per 100 cm 2 are limited to the new 5 cm high abdominal region of interest. Multivariable models adjusted for: age at baseline, region, education, income, race and ethnicity, hormone therapy trial arm, diet modification trial arm, calcium and vitamin D trial arm, height at baseline, alcohol intake, smoking status, physical activity (MET-hrs/wk), physical function (SF 36 score), total energy intake (kcal/day), HEI-2015 score, hormone therapy, aspirin, metformin, female relative with breast cancer, age at menarche, age at first birth, total number of months of breastfeeding, age at menopause, and surgical menopause. VAT: Visceral adipose tissue; SAT: Abdominal subcutaneous adipose tissue; TAT: Total abdominal adipose tissue; Q: Quartile; SHR: Sub-hazard ratio; CI: Confidence interval; WHI: Women’s Health Initiative; <t>DXA:</t> Dual-energy X-ray absorptiometry.
Densitometer, supplied by Hologic Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dexa+scans+hologic+discovery+model+a/densitometer/pm27812609-97-23-25
Average 86 stars, based on 1 article reviews
densitometer - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier
hologic discovery a  (Hologic Inc)
86
Hologic Inc hologic discovery a
Multivariable-adjusted associations between ( A ) baseline and ( B ) time-varying adiposity variables and breast cancer-related mortality in the Women’s Health Initiative dual-energy X-ray absorptiometry cohort ( n = 9767; breast cancer-related deaths: 87). VAT, SAT, and TAT per 100 cm 2 are limited to the new 5 cm high abdominal region of interest. Multivariable models adjusted for: age at baseline, region, education, income, race and ethnicity, hormone therapy trial arm, diet modification trial arm, calcium and vitamin D trial arm, height at baseline, alcohol intake, smoking status, physical activity (MET-hrs/wk), physical function (SF 36 score), total energy intake (kcal/day), HEI-2015 score, hormone therapy, aspirin, metformin, female relative with breast cancer, age at menarche, age at first birth, total number of months of breastfeeding, age at menopause, and surgical menopause. VAT: Visceral adipose tissue; SAT: Abdominal subcutaneous adipose tissue; TAT: Total abdominal adipose tissue; Q: Quartile; SHR: Sub-hazard ratio; CI: Confidence interval; WHI: Women’s Health Initiative; <t>DXA:</t> Dual-energy X-ray absorptiometry.
Hologic Discovery A, supplied by Hologic Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dexa+scans+hologic+discovery+model+a/a+discovery+hologic/10__51253_slash_pafmj__v74i2__9391-37-6-12
Average 86 stars, based on 1 article reviews
hologic discovery a - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier
accelerometer actigraph gt3x  (ActiGraph llc)
90
ActiGraph llc accelerometer actigraph gt3x

Accelerometer Actigraph Gt3x, supplied by ActiGraph llc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dexa+scans+hologic+discovery+model+a/actigraph+gt3x/pmc09852481-3-81-82
Average 90 stars, based on 1 article reviews
accelerometer actigraph gt3x - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


Multivariable-adjusted associations between ( A ) baseline and ( B ) time-varying adiposity variables and breast cancer-related mortality in the Women’s Health Initiative dual-energy X-ray absorptiometry cohort ( n = 9767; breast cancer-related deaths: 87). VAT, SAT, and TAT per 100 cm 2 are limited to the new 5 cm high abdominal region of interest. Multivariable models adjusted for: age at baseline, region, education, income, race and ethnicity, hormone therapy trial arm, diet modification trial arm, calcium and vitamin D trial arm, height at baseline, alcohol intake, smoking status, physical activity (MET-hrs/wk), physical function (SF 36 score), total energy intake (kcal/day), HEI-2015 score, hormone therapy, aspirin, metformin, female relative with breast cancer, age at menarche, age at first birth, total number of months of breastfeeding, age at menopause, and surgical menopause. VAT: Visceral adipose tissue; SAT: Abdominal subcutaneous adipose tissue; TAT: Total abdominal adipose tissue; Q: Quartile; SHR: Sub-hazard ratio; CI: Confidence interval; WHI: Women’s Health Initiative; DXA: Dual-energy X-ray absorptiometry.

Journal: Current Oncology

Article Title: DXA-Derived Visceral and Subcutaneous Adipose Tissue and Postmenopausal Breast Cancer Mortality

doi: 10.3390/curroncol33020119

Figure Lengend Snippet: Multivariable-adjusted associations between ( A ) baseline and ( B ) time-varying adiposity variables and breast cancer-related mortality in the Women’s Health Initiative dual-energy X-ray absorptiometry cohort ( n = 9767; breast cancer-related deaths: 87). VAT, SAT, and TAT per 100 cm 2 are limited to the new 5 cm high abdominal region of interest. Multivariable models adjusted for: age at baseline, region, education, income, race and ethnicity, hormone therapy trial arm, diet modification trial arm, calcium and vitamin D trial arm, height at baseline, alcohol intake, smoking status, physical activity (MET-hrs/wk), physical function (SF 36 score), total energy intake (kcal/day), HEI-2015 score, hormone therapy, aspirin, metformin, female relative with breast cancer, age at menarche, age at first birth, total number of months of breastfeeding, age at menopause, and surgical menopause. VAT: Visceral adipose tissue; SAT: Abdominal subcutaneous adipose tissue; TAT: Total abdominal adipose tissue; Q: Quartile; SHR: Sub-hazard ratio; CI: Confidence interval; WHI: Women’s Health Initiative; DXA: Dual-energy X-ray absorptiometry.

Article Snippet: In short, DXA scans (QDR2000, 2000+, or 4500W DXA models and QDR software v12.1, Hologic Inc., Bedford, MA, USA) were performed to measure total and regional adiposity and lean soft tissue at baseline, Year 3, and Year 6 [ ].

Techniques: Modification, Activity Assay

Journal: Data in Brief

Article Title: A dataset on skeletal muscle mass index, body composition and strength to determinate sarcopenia in bariatric patients

doi: 10.1016/j.dib.2022.108881

Figure Lengend Snippet:

Article Snippet: How the data were acquired , Anthropometry: Scale and stadiometer. Body composition: Dual-energy X-ray absorptiometry - DEXA (DXA, Hologic QDR Hologic USA) Muscle strength: Manual pressure dynamometry (Handgrip) for upper limbs. The muscle strength of the lower limbs will be evaluated by the sit to stand test. The strength of lower limbs, as well as muscle fatigue, will be evaluated with an isokinetic dynamometer (Biodex®, System 3 Pro USA) Cardiorespiratory fitness: the 6-minute walk test (TC6) Sedentary Behavior and Physical Activity: Accelerometer (ActiGraph GT3X model, Fort Walton Beach, Florida, USA) for 5 days before the surgery and after the exercise program.

Techniques: Activity Assay